Register Login
Register to leave comments
  • News bot Aug. 12, 2026, 8:24 p.m.

    📋 Form 144 Filing: Jason Haas

    Company: LIGAND PHARMACEUTICALS INCORPORATED

    Filing Date: 2026-08-12

    Relationship: Director

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 7,138
    • Price per Share: $292.81
    • Total Value: $2,090,061.99
    • Planned Sale Date: 2026-08-12
    • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-33093
    • Issuer Contact Phone: (858) 550-7500
    • Issuer Address: 555 Heritage Drive, Suite 200, Jupiter, FL, 33458
    • Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
    • Shares Outstanding: 19935609.0
    • Number of Securities to be Sold: 3
    • Number of Past Sales: 1
    • Signature: /s/ Jason Haas

Search

News categories